Abstract: Objective To investigate the clinical efficacy and application value of robot-assisted endometrial cancer staging surgery. Methods We retrospectively analyzed 30 patients underwent robot-assisted endometrial cancer staging surgery from March 2010 to March 2015. Results The mean operation time was （218.2±32.5）min. The mean intraoperative blood loss was （136.8±60.1）ml. The mean number of lymph node was （23.9±4.4）. The mean postoperative bowel recovery time was （1.3±0.6）d. The mean time of antibiotic usage was （5.1±3.7）d， and the mean postoperative hospital stay time was （9.2±5.3）d. Three cases experienced urinary tract infection，1 case experienced pelvic lymph cyst，and 1 case experienced limb thrombosis. Conclusion Robot-assisted endometrial cancer staging surgery is safe and feasible.